Segment Reporting Sig Items (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Restructuring and asset related charges - net	[1]	$ (288)	$ (336)	$ (363)
Estimated Settlement Expense	[2]	(101)	(204)	(87)
Inventory Write-down	[3]		(12)
Gain (loss) on sale of business, assets and equity investments		17	22	18
Employee Retention Credit			3	9
AltEn facility remediation charges			(10)	(33)
Acquisition Related Costs	[4]	(6)	(45)
Insurance Proceeds	[5]	71
Net Sales		16,908	17,226	17,455
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net Sales		16,908	17,226	17,455
2022 Restructuring Actions
Segment Reporting Information [Line Items]
Inventory Write-down	[6]	2	(7)	(33)
Gain (loss) on sale of business, assets and equity investments	[6]	7	14	10
2022 Restructuring Actions - Russia Exit
Segment Reporting Information [Line Items]
Seed sale associated with Russia Exit	[6],[7]		(18)	(3)
2022 Restructuring Actions - Russia Exit | Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]
Segment Reporting Information [Line Items]
Net Sales		71	8
Cost of Revenue		53	5
Settlement with Taxing Authority | 2022 Restructuring Actions - Russia Exit
Segment Reporting Information [Line Items]
Settlement costs associated with Russia Exit	[6]			(8)
Seed [Member]
Segment Reporting Information [Line Items]
Restructuring and asset related charges - net	[1]	(55)	(86)	(228)
Estimated Settlement Expense	[2]	0	0	0
Inventory Write-down	[3]		0
Gain (loss) on sale of business, assets and equity investments	[6]		4	(5)
Employee Retention Credit			0	6
AltEn facility remediation charges			(10)	(33)
Acquisition Related Costs	[4]	0	0
Other Nonrecurring Income		(49)	(81)	(298)
Net Sales		9,545	9,472	8,979
Seed [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net Sales		9,545	9,472	8,979
Seed [Member] | 2022 Restructuring Actions
Segment Reporting Information [Line Items]
Inventory Write-down	[6]	2	(7)	(33)
Gain (loss) on sale of business, assets and equity investments	[6]	4
Seed [Member] | 2022 Restructuring Actions - Russia Exit
Segment Reporting Information [Line Items]
Seed sale associated with Russia Exit	[6],[7]		(18)	(3)
Seed [Member] | Settlement with Taxing Authority | 2022 Restructuring Actions - Russia Exit
Segment Reporting Information [Line Items]
Settlement costs associated with Russia Exit	[6]			(8)
Crop Protection [Member]
Segment Reporting Information [Line Items]
Restructuring and asset related charges - net	[1]	(142)	(228)	(37)
Estimated Settlement Expense	[2]	(101)	(204)	(87)
Inventory Write-down	[3]		(12)
Gain (loss) on sale of business, assets and equity investments	[6]		10	15
Employee Retention Credit			3	3
AltEn facility remediation charges			0	0
Acquisition Related Costs	[4]	(6)	(45)
Other Nonrecurring Income		(175)	(476)	(106)
Insurance Proceeds	[5]	71
Net Sales		7,363	7,754	8,476
Crop Protection [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net Sales		7,363	7,754	8,476
Crop Protection [Member] | 2022 Restructuring Actions
Segment Reporting Information [Line Items]
Inventory Write-down	[6]	0	0	0
Gain (loss) on sale of business, assets and equity investments	[6]	3
Crop Protection [Member] | 2022 Restructuring Actions - Russia Exit
Segment Reporting Information [Line Items]
Seed sale associated with Russia Exit	[6],[7]		0	0
Crop Protection [Member] | Settlement with Taxing Authority | 2022 Restructuring Actions - Russia Exit
Segment Reporting Information [Line Items]
Settlement costs associated with Russia Exit	[6]			0
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Restructuring and asset related charges - net	[1]	(91)	(22)	(98)
Other Nonrecurring Income		$ (91)	$ (22)	$ (98)

[1] Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 6 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.

[2] Consists of estimated Lorsban® related charges.

[3] Incremental loss associated with activities related to the Crop Protection Operations Strategy Restructuring Program.

[4] Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 4 - Business Combinations, to the Consolidated Financial Statements, for additional information.

[5] Includes proceeds received related to prior significant items.

[6] Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions.

[7] Includes a benefit of $18 million and $3 million for the years ended December 31, 2023 and 2022, respectively, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the Company was contractually required to purchase. It consists of $71 million and $8 million of net sales and $53 million and $5 million of cost of goods sold for the years ended December 31, 2023 and 2022, respectively.